Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-043003
Filing Date
2026-06-12
Accepted
2026-06-12 21:06:59
Documents
1
Period of Report
2026-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1781312816.html 4  
1 FORM 4 wk-form4_1781312816.xml 4 5784
  Complete submission text file 0001628280-26-043003.txt   7569
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5401 WEST KENNEDY BOULEVARD, SUITE 890 TAMPA FL 33609
Business Address
Froimson Mark (Reporting) CIK: 0001709050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 261088840